Cargando…
Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529601/ https://www.ncbi.nlm.nih.gov/pubmed/30852622 http://dx.doi.org/10.1007/s00262-019-02320-0 |
| _version_ | 1783420432971464704 |
|---|---|
| author | Koster, Bas D. Santegoets, Saskia J. A. M. Harting, Jorien Baars, Arnold van Ham, S. Marieke Scheper, Rik J. Hooijberg, Erik de Gruijl, Tanja D. van den Eertwegh, Alfons J. M. |
| author_facet | Koster, Bas D. Santegoets, Saskia J. A. M. Harting, Jorien Baars, Arnold van Ham, S. Marieke Scheper, Rik J. Hooijberg, Erik de Gruijl, Tanja D. van den Eertwegh, Alfons J. M. |
| author_sort | Koster, Bas D. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6529601 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-65296012019-06-07 Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial Koster, Bas D. Santegoets, Saskia J. A. M. Harting, Jorien Baars, Arnold van Ham, S. Marieke Scheper, Rik J. Hooijberg, Erik de Gruijl, Tanja D. van den Eertwegh, Alfons J. M. Cancer Immunol Immunother Clinical Trial Report Springer Berlin Heidelberg 2019-03-09 2019 /pmc/articles/PMC6529601/ /pubmed/30852622 http://dx.doi.org/10.1007/s00262-019-02320-0 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
| spellingShingle | Clinical Trial Report Koster, Bas D. Santegoets, Saskia J. A. M. Harting, Jorien Baars, Arnold van Ham, S. Marieke Scheper, Rik J. Hooijberg, Erik de Gruijl, Tanja D. van den Eertwegh, Alfons J. M. Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial |
| title | Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial |
| title_full | Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial |
| title_fullStr | Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial |
| title_full_unstemmed | Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial |
| title_short | Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial |
| title_sort | autologous tumor cell vaccination combined with systemic cpg-b and ifn-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase ii trial |
| topic | Clinical Trial Report |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529601/ https://www.ncbi.nlm.nih.gov/pubmed/30852622 http://dx.doi.org/10.1007/s00262-019-02320-0 |
| work_keys_str_mv | AT kosterbasd autologoustumorcellvaccinationcombinedwithsystemiccpgbandifnapromotesimmuneactivationandinducesclinicalresponsesinpatientswithmetastaticrenalcellcarcinomaaphaseiitrial AT santegoetssaskiajam autologoustumorcellvaccinationcombinedwithsystemiccpgbandifnapromotesimmuneactivationandinducesclinicalresponsesinpatientswithmetastaticrenalcellcarcinomaaphaseiitrial AT hartingjorien autologoustumorcellvaccinationcombinedwithsystemiccpgbandifnapromotesimmuneactivationandinducesclinicalresponsesinpatientswithmetastaticrenalcellcarcinomaaphaseiitrial AT baarsarnold autologoustumorcellvaccinationcombinedwithsystemiccpgbandifnapromotesimmuneactivationandinducesclinicalresponsesinpatientswithmetastaticrenalcellcarcinomaaphaseiitrial AT vanhamsmarieke autologoustumorcellvaccinationcombinedwithsystemiccpgbandifnapromotesimmuneactivationandinducesclinicalresponsesinpatientswithmetastaticrenalcellcarcinomaaphaseiitrial AT scheperrikj autologoustumorcellvaccinationcombinedwithsystemiccpgbandifnapromotesimmuneactivationandinducesclinicalresponsesinpatientswithmetastaticrenalcellcarcinomaaphaseiitrial AT hooijbergerik autologoustumorcellvaccinationcombinedwithsystemiccpgbandifnapromotesimmuneactivationandinducesclinicalresponsesinpatientswithmetastaticrenalcellcarcinomaaphaseiitrial AT degruijltanjad autologoustumorcellvaccinationcombinedwithsystemiccpgbandifnapromotesimmuneactivationandinducesclinicalresponsesinpatientswithmetastaticrenalcellcarcinomaaphaseiitrial AT vandeneertweghalfonsjm autologoustumorcellvaccinationcombinedwithsystemiccpgbandifnapromotesimmuneactivationandinducesclinicalresponsesinpatientswithmetastaticrenalcellcarcinomaaphaseiitrial |